Call Start: 16:30 January 1, 0000 5:34 PM ET
New Pacific Biosciences of California (NASDAQ:PACB)
Q3 2021 Earnings Conference Call
November 2, 2021 16:30 ET
Company Participants
Todd Friedman - Director of Investor Relations
Christian Henry - President, Chief Executive Officer & Director
Susan Kim - Chief Financial Officer
Mark Van Oene - Chief Operating Officer
Conference Call Participants
Tycho Peterson - JPMorgan Chase
Kyle Mikson - Canaccord Genuity
Tejas Savant - Morgan Stanley
Dan Brennan - Cowen & Company
Operator
Good day, everyone and thank you for standing by. Welcome to the Pacific Biosciences of California Incorporated Third Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. And after the speakers presentation, there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to the Director of Investor Relations, Mr. Todd Friedman. Please go ahead, sir.
Todd Friedman
Good afternoon and welcome to PacBio's third quarter 2021 earnings conference call. Earlier today, we issued a press release outlining the financial results we will be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com, or alternatively as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. With me today are Christian Henry, President and Chief Executive Officer; Susan Kim, Chief Financial Officer; and Mark Van Oene, Chief Operating Officer.
Before we begin, I'd like to remind you that on today's call, we will be making forward-looking statements, including providing predictions, estimates, plans, expectations and other information. You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks and uncertainties and may differ materially from actual results. These risks and uncertainties are more fully described in our press release issued earlier today and in our filings with the
- Read more current PACB analysis and news
- View all earnings call transcripts